Company profile for Mind Medicine

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Mind Medicine (MindMed) Inc. is a neuro-pharmaceutical company that discovers, develops and deploys psychedelic inspired medicines to improve health, promote wellness and alleviate suffering. The company's immediate priority is to address the opioid crisis by developing a non-hallucinogenic version of the psychedelic ibogaine. In addition, the company has established a microdosing division to conduct clinical trials of LSD mic...
Mind Medicine (MindMed) Inc. is a neuro-pharmaceutical company that discovers, develops and deploys psychedelic inspired medicines to improve health, promote wellness and alleviate suffering. The company's immediate priority is to address the opioid crisis by developing a non-hallucinogenic version of the psychedelic ibogaine. In addition, the company has established a microdosing division to conduct clinical trials of LSD microdosing for adult ADHD. The MindMed executive team brings extensive biopharmaceutical industry experience to this groundbreaking approach to the development of next-generation psychedelic medicines.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
One World Trade Center, Suite 8500, New York, NY 10007
Telephone
Telephone
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20251201889406/en/MindMed-Announces-New-Employee-Inducement-Grants

BUSINESSWIRE
01 Dec 2025

https://www.businesswire.com/news/home/20251106771034/en/MindMed-Reports-Q3-2025-Financial-Results-and-Business-Updates

BUSINESSWIRE
06 Nov 2025

https://www.businesswire.com/news/home/20251105303331/en/MindMed-to-Participate-in-Upcoming-Investor-Conferences

BUSINESS WIRE
05 Nov 2025

https://www.businesswire.com/news/home/20251103786666/en/Mind-Medicine-MindMed-Inc.-Announces-Closing-of-Approximately-%24259-Million-Public-Offering-Including-Full-Exercise-of-the-Underwriters-Option-to-Purchase-Additional-Shares

BUSINESSWIRE
03 Nov 2025

https://www.businesswire.com/news/home/20251103934174/en/MindMed-Announces-New-Employee-Inducement-Grant

BUSINESSWIRE
03 Nov 2025

https://www.businesswire.com/news/home/20251030210258/en/MindMed-to-Report-Q3-2025-Financial-Results-on-November-6-2025

BUSINESSWIRE
30 Oct 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty